<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-21T01:32:05Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/13019" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/13019</identifier><datestamp>2024-10-11T02:21:24Z</datestamp><setSpec>com_201003_14372</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14374</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Fas-associated factor 1 is involved in neurofibrillary tangle-mediated cell death of basal forebrain cholinergic neurons in P301L transgenic mice</dc:title>
<dc:title>P301L 형질전환 마우스에서 FAF1과 Neurofibrillary tangles에 의한 basal forebrain의 콜린성 신경세포 사멸</dc:title>
<dc:creator>김, 종무</dc:creator>
<dc:contributor>이, 영돈</dc:contributor>
<dc:contributor>대학원 의생명과학과</dc:contributor>
<dc:contributor>201125165</dc:contributor>
<dc:contributor>김, 종무</dc:contributor>
<dc:subject>P301L transgenic mice</dc:subject>
<dc:subject>septal region</dc:subject>
<dc:subject>tau phosphorylation</dc:subject>
<dc:subject>Alzheimer's disease</dc:subject>
<dc:description>PART I 1 &#xd;
&#xd;
Ⅰ. INTRODUCTION 2 &#xd;
&#xd;
  A. Basal forebrain of mammals 2 &#xd;
&#xd;
  B. Neuron types in the basal forebrain 2 &#xd;
&#xd;
  C. Alzheimer&amp;rsquo;s disease 3 &#xd;
&#xd;
  D. Normal functions of tau protein 4 &#xd;
&#xd;
  E. Structure and Posttranslational Modifications of the Tau Protein 5 &#xd;
&#xd;
  F. Distribution of tau phosphorylation sites and NFT formation in AD brains 7 &#xd;
&#xd;
  G. Monoclonal antibody AT8 recognizes tau phosphorylation 11 &#xd;
&#xd;
  H. Cholinergic dysfunction in the basal forebrain in AD cases 12 &#xd;
&#xd;
  I. FTDP-17 13 &#xd;
&#xd;
  J. Cholinergic dysfunction in P301L transgenic mice 14 &#xd;
&#xd;
Ⅱ. MATERIALS AND METHODS 16 &#xd;
&#xd;
  1. Animals 16 &#xd;
&#xd;
  2. Antibodies 16 &#xd;
&#xd;
  3. Immunohistochemistry 16 &#xd;
&#xd;
  4. Thioflavin-S staining 17 &#xd;
&#xd;
  5. Sarkosyl fraction of Tau protein and immunoblotting 17 &#xd;
&#xd;
  6. Stereological analysis 18 &#xd;
&#xd;
  7. Statistical analysis 19 &#xd;
&#xd;
Ⅲ. RESULTS 20 &#xd;
&#xd;
Ⅳ. DISCUSSION 28 &#xd;
&#xd;
Ⅴ. CONCLUSION 30 &#xd;
&#xd;
PART II 31 &#xd;
&#xd;
 ABSTRACT 32 &#xd;
&#xd;
Ⅰ. INTRODUCTION 34 &#xd;
&#xd;
  A. Reelin expression in GABAergic neurons 34 &#xd;
&#xd;
  B. Reelin structure 36 &#xd;
&#xd;
  C. Reelin fragments 38 &#xd;
&#xd;
  D. Reelin receptors and reelin signaling 39 &#xd;
&#xd;
  E. The involvement of Reelin signaling in neuropsychiatric disorders 41 &#xd;
&#xd;
  F. Astrogliosis 41 &#xd;
&#xd;
Ⅱ. MATERIALS AND METHODS 44 &#xd;
&#xd;
  1. Animals 44 &#xd;
&#xd;
  2. Brain section preparation and Immunohistochemistry 44 &#xd;
&#xd;
  3. Stereological analysis 45 &#xd;
&#xd;
  4. Western blot analysis 45 &#xd;
&#xd;
  5. Statistical analysis 46 &#xd;
&#xd;
Ⅲ. RESULTS  47 &#xd;
&#xd;
Ⅳ. DISCUSSION 64 &#xd;
&#xd;
Ⅴ. CONCLUSION 66 &#xd;
&#xd;
 CONCLUSION OF PART I, II 67 &#xd;
&#xd;
PART III 69 &#xd;
&#xd;
 ABSTRACT 70 &#xd;
&#xd;
Ⅰ. INTRODUCTION 72 &#xd;
&#xd;
  A. Mammalian neocortex 73 &#xd;
&#xd;
  B. Reelin function in the developing cortex 73 &#xd;
&#xd;
  C. Preplate and preplate splitting 75 &#xd;
&#xd;
Ⅱ. MATERIALS AND METHODS 77 &#xd;
&#xd;
  1. Animals 77 &#xd;
&#xd;
  2. Production of recombinant Reelin 77 &#xd;
&#xd;
  3. Culture of neurospheres 78 &#xd;
&#xd;
  4. Immunofluorescence 79 &#xd;
&#xd;
Ⅲ. RESULTS 81 &#xd;
&#xd;
Ⅳ. DISCUSSION 99 &#xd;
&#xd;
Ⅴ. CONCLUSION 103 &#xd;
&#xd;
REFERENCES 104 &#xd;
&#xd;
국문요약 116</dc:description>
<dc:description>Doctor</dc:description>
<dc:date>2016-11-27T22:49:16Z</dc:date>
<dc:date>2016-11-27T22:49:16Z</dc:date>
<dc:date>2016</dc:date>
<dc:date>2016</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/13019</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000021554</dc:identifier>
<dc:identifier>000000021554</dc:identifier>
<dc:language>en</dc:language>
<dc:format>application/pdf</dc:format>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>